ACTIVE

ASYLIA DIAGNOSTICS

Financial year 2024 · Closed on 31/12/2024

Net result-183,9 k €-17,9 %over 1 year
Gross margin-125,1 k €-95,9 %over 1 year
Equity109,2 k €-62,7 %over 1 year

Identity

Source · BCE/KBO

ASYLIA DIAGNOSTICS is a Private limited company incorporated in 2019. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0732.783.629
Incorporation
22/08/2019
Legal form
Private limited company
Registered office
Philipssite 5 box 1
3001 Leuven · FlandreSee on map
Contributed capital
579 920,90 €
Latest accounts
31/12/2024
Joint committees (1)
  • 200
Signals
Good liquidityHealthy social debts

Financials

Source · NBB, 6 filings

Trend over 5 financial years

20242023202220212020
Income statement
Gross margin-125,1 k €-63,9 k €163,4 k €-126,8 k €-62,9 k €
EBITDA-127,2 k €-81 k €145,5 k €-139,9 k €-64,9 k €
Operating result-183,3 k €-153,1 k €75,5 k €-140,8 k €-64,9 k €
Net result-183,9 k €-156 k €75,6 k €-141,5 k €-65 k €
Balance sheet
Equity109,2 k €293,1 k €449,1 k €118,5 k €60 k €
Total assets552,1 k €718,4 k €923,7 k €721,9 k €301,4 k €
Cash22,9 k €48,5 k €151,9 k €494,3 k €295,9 k €
Debts439,4 k €423,3 k €474,3 k €592,6 k €241,5 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

3 active

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Andrey KHMELEVSKIY
Directorsince 22/08/2019
Anna KOSTIKOVA
Directorsince 22/08/2019
PharmaLegal0541.432.719Represented by DE FEU Georges
Directorsince 22/08/2019

Other companies at this address

Philipssite 5 3001 Leuven
CompanyCBE no.
AABDC● Liquidation
0731.674.562
0750.680.921
0454.240.706
AgriFoodInvest● Active
0804.614.604
Arcsec● Active
0745.758.566
ARLETTE WOOD● Active
0787.717.697
B.A.● Active
0479.645.501
0889.512.467
1032.292.509
CHRISTY● Active
0456.993.526
Coleus● Active
0705.888.695
0541.439.449
CREANDO● Active
0824.417.450
Deal Advisor● Active
1035.583.876
De Raaf● Active
0805.300.928
DIGITAL UNITY● Active
0717.823.358
DRAKA BELGIUM● Active
0423.221.589
EconCore● Active
0878.425.664
1014.144.995
EIT FOOD● Active
0672.423.992

Full financial information

Source · NBB
20242023202220212020
Type of accountMicro modelMicro modelMicro modelAbridged modelMicro model
Start of the financial year01/01/202401/01/202301/01/202201/01/202122/08/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months17 months
Filing date04/07/202508/08/202410/08/202323/09/202228/07/2021
General meeting30/06/202517/07/202430/06/202322/09/202226/07/2021
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 6 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202430/06/202504/07/2025DutchPDF
Micro model31/12/202317/07/202408/08/2024DutchPDF
Micro model31/12/202230/06/202310/08/2023DutchPDF
Abridged model31/12/202122/09/202223/09/2022DutchPDF
Micro model31/12/202114/07/202215/07/2022DutchPDF
Micro model31/12/202026/07/202128/07/2021DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

3 active

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Andrey KHMELEVSKIY
Directorsince 22/08/2019
Anna KOSTIKOVA
Directorsince 22/08/2019
PharmaLegal0541.432.719Represented by DE FEU Georges
Directorsince 22/08/2019

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office14/03/2025
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Capital / shares20/02/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Other26/08/2019
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings5 filings
Mandates
PharmaLegal
Andrey KHMELEVSKIY
Anna KOSTIKOVA
20192020202120222023202420252026
ASYLIA DIAGNOSTICS
Turnhoutseweg 30, 2340 Beerse
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Philipssite 5 bte 1, 3001 HeverleeCurrent
CBE
Philipssite 5/1, 3001 Heverlee
accounts 2024
Accounts 2024 · 2025-00244771
Turnhoutseweg 30, 2340 Beerse
accounts 2021 → 2023
Accounts 2023 · 2024-00337880

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
ASYLIA DIAGNOSTICSCurrent
accounts 2020 → 2024
Accounts 2024 · 2025-00244771

Events

  1. 2024
    Annual accounts 2024-183,9 k €↓
  2. 2023
    Annual accounts 2023-156 k €↓
  3. 2022
    Annual accounts 202275,6 k €↑
  4. 2021
    Annual accounts 2021-141,5 k €↓
  5. 2020
    Annual accounts 2020-65 k €
  6. 22/08/2019
    IncorporationPrivate limited company